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Abstract
BaqlrsrouRd
Cr**-' di**e is the most corlmon cause of hyperthyroidism. Despite receiving
treatment for hlperthyroidism, symptoms often persist, despite being chemically
euthyroid. By pd.fo*ring this rttrOy, the researcher hoped to learn how the persistence of
these symptoms affects quality of life in Graves' disease.
Methods
ffi"-*tionnaire used was adapted from the Hyperthyroidism Complaint Questionnaire
designed by Fahrenfort and Wil,terdink, with results published in the February 2000 issue
of psychoneuroendocrinoloy. The modified questionnaire was sent to members of the
National Graves' Disease Foundation. Respondents were questioned on symptoms and
affects on relationships, careers and overall functioning. Data was analyzed using the
Statistical package forthe Social Sciences (SPSS) for frequency of responses, and by
using Pearson's correlation coefficient-
Res.ults
Gffi-on persistent complaints included feeling easily stressed, memory problems,
decreased ensrgy and desreased libido. Over Z|o/oof respondents indicated relationships
had struggled, iiting more frequent conflicts and feeling others lack rrnderstanding for
their feJi"gs. Respondents also indicated Graves' had affected their careers.
Coqclusip,us
Rffiindisated the persistence of several symptoms and also found their
relaiionship*, carsers, and daily functioning affected. These areas are important in
helping to determine satisfaction with life and therefore, it was determined that Graves'
disease can adversely affect qualiry of life.
lv
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Quality of Life 1
Chapter One - Introduction
Graves' disease is the most cofirmon cause of hyperthyroidism. Those afflicted
with Graves' disease may experience physical, mental, and emotional rnanifestations of
the disease. patients with Graves' disease frequently present with physical complaints
such as weight loss, decreased tolerance to heat, fatigue, increased bowel movetnents,
palpitations, and menstrual irregularity in females (Tierney, McPhee, and Papadakis,
2001). In addition to these physical manifestations, patients may also experience
dysfunction in their emotional health as well as their cognitive functioning- Common
non-physical complaints include emotional tability, anxiety, restlesslless, sleep
disturbance, and impaired concentration (Rockey and Griep, 1980). The research is
inconclusive as to whether these symptoms resolve once the patient has been treated and
has reashed a euthyroid state (Bommer, Eversmann, Piskardt, Leonhardt, and Naber,
1 ee0).
An ideal treafinent plan, which would establish a balance between control of
thyrotoxicosis and prevention of subsequent hypothyroidism, is yet to be developed
(Calegaro, De Freitas Gomes, Bae, Ulyssea, ffid Casulari, 2000). Nevertheless, there are
three main modalities of treatment for hyperthyroidism; antithyroid drugs, surgery, and
radioiodine. Of these, radioiodine is the most widely used modality in the United States
(Ljunggren, Torring, Wallin, Taube, Tallstedt, Hamberger, and Lundell, 1998), in Great
Britain (Berg, Michanek, Holmberg, and Nystrom, 1996), flsd, "is the preferred therapy
of middle-aged and elderly patients with hyperthyroidism caused by Graves' disease
(GD) in many hospitals" in Sweden (Berg et al., 1996), The findings from one study
comparing the efficacy of the three main treatment modalities confirmed that although
treatment with radioiodine is likety to be followed by hypothyroidism, it does appear to
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be the most successful treatment method available for controlling hyperthyroidism
(Leary, Grealy, Higgins, Buckley', Barry, and Murphy, 1999)'
While sorne people treated for Graves' disease are able to return to their pre-
disease state of health, others are left with a feeling that something is not right. After
being in an errdocrinologic state of hyperthyroidism often for an extended period of time
before their diagnosis is made, these patients may then enter a state of hypothyroidism
relatively suddenly following treatment (Berg et al., 1996). The natural assumption
following a successful treatment course for most any disease is that the symptoms will
either disappear or will be significantly lessened. Unforfunately for some patients with
Graves, disease, though the original symptoms characteristic of hyperthyroidism (weight
loss, heat intolerance, ernotional lability, etc.) may fade, they may begin to experience
symptoms of hypothyroidism (weight gain, fatigue, intolerance to cold temperatures,
constipation, etc.). The severity of the symptoms following treatment may be related, at
least in part, to how rapidly the individual experiences the change from hyperthyroidism
to hypothyroidism. ..Hyperthyroid patients who become rapidly hypothyroid after
radioiodine are known to be extremely symptomatic, with often the presence of severe
muscle pains and depression in addition to the usual clinical feafifies" (Segers, Musch,
and Schoors, 1993, P. 255),
The persistence of symptoms, following what is considered by their rnedical
providers to be a suscessful treatment course, can be both physically and emotionally
draining for these patients. Not only do patients treated for hyperthyroidism continue to
have physical symptoms, but they may also experience relatively long-lasting cognitive
effects, including problems with memory, critical thinking and concentration (Bommer et
al., 1gg0). considering the continued diffrculty patients can experience after treatment of
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Graves, disease, along with the possibility of becoming endocrinologically hypothyroid,
it seems as though long term follow-up is impor[ant in these individuals' ". . - Although
therapy has been successful in eliminating the hyperfunction of the thyroid, other (health)
problems may be present which necessitates a long follow-up in these patients" (Berg et
al., 1996, p. 170).
Statement of the Problem
The researcher aimed to learn how patients with Graves' had been impacted by
the disease. Graves' disease seemed to be a potentially disabling disease to many facets
of a person,s life, including their mental, physical, ffid cognitive health. By completing
this study on the selected population, the investigator attempted to learn how, if at all, the
patients, personal relationships had changed since the onset of their disease, as well as
how their self-esteem had been affected, if at all. In addition, the investigator sought to
determine how the patients' physical health and cognitive functioning had been affected,
and whether the disease had caused a change in their ability to flmction, both at work and
in the home. Therefore, the topic of this study was to determine how one's quahty of life
is affected following a diagnosis with Graves' disease.
Purpose of the StudY
Graves, disease affects less than 111000 individuats in the United States (National
Graves, Disease Foturdation, 2000, p. 2) with over 37,000 newly diagnosed cases per
year (American Autoimmune Related Diseases Association, lnc', n-d', flZ)- Although
Graves, is not one of the most common diseases, it is important health care providers are
aware not only of the most coillmon sigus and syrnptoms, but also of the long term
sequelae endured by those with the disease. The purpose of this study was to determine
first of all, if those with Graves' disease experienced negative eflects on their perceived
Quality of Life 4
quality of life. Secondly, the researcher hoped to give the reader (be they patients, family
members of patients, or health sare providers) a greater awareness of the disease's
sequelae. Increased awareness in patients may hetp them feel less isolated in their
struggle with Graves' disease. Similarly, giving loved ones and health care providers a
greater understanding of what someone dealing with Graves' disease endures may
ultimately help the patients cope more effectively.
Graves' disease is a multifaceted disease; one which requires care by a
multidisciplinary team approach. Patients may require the care of a primary cilre
clinician, an endocrinologist, and possibly a psychiatrist or other mental health care
specialist. This is a disease that has distinct potential to affect a Person's psychological
well-being. The idea of counseling should not be ignored and should even be encouraged
if either the patient or the provider believes it might provide benefit. "Involvement of
mental health care providers who are faffriliar with neuropsychiatric differential
diagnostic issues should prove helpful in the management of patients with Graves'
disease, both at initial presentation and later in the course of the illness" (Stern,
Robinson, Thorner, Amrda Prohaska, and Prange, 1996, p- 185).
Definition of Terms
In the following section, several terms are defined. The terms are defined as they
were intended to be understood fbr the purposes of this study. Definitions were obtained
or slightly adapted from Taber's Cyclopedic Medical Dictionary, Nineteenth Edition
(Venes, 2001).
E-uthwoid is defined as having a normally fimctioning thyroid gland-
Gravesl disease is def,rned as a distinct type of hyperthyroidism caused by an
autoimmune attack on the thyroid gland. It typically produces enlargement of the thyroid
Quality of Life 5
gland and also may cause ocular findings (including proptosis, lid lag, and stare), and
pretibial myxedema.
Hyp.erthwoidism is defined as a disease caused by excessive levels of thyroid
hormone in the bodY.
Hypothyroidi$m is defined as the clinical consequences of inadequate levels of
thyroid hormone in the body. When thyroid deficiency is long-standing or severe, it
results in diminished basal metabolism, intolerance of the cold temperatures, fatigue,
mental apathy, physical sluggishness, constipation, muscle aches, dry skin and hair, arrd
coarsening of features.
Mental illness is defined as any condition that affects mood or behavior, such as
depression, dysphoria, personality disorders, phobias, schizophreniq or substance abuse,
among others.
Multidisciplinar,v is defined as relating to multiple fields of study involved in the
care of patients. The term suggests that the various disciplines are working in
collaboration, but in a parallel mode of interaction. Each distinctive discipline is
accountable and responsible for its tasks and functions regarding patient care-
Myxede.ma is defined as the infiltration of the skin by mucopolysaccharides,
giving it a waxy or coarsened appearance. Myxedematous skin is seen particularly in
patients with hyPothYroidism-
ophth+lmopathy is defined as any disease of the eye.
eualiqv of life is defined as the worth, meaning, or satisfaction obtained from
living. The concept holds varying meanings for different people and may evolve over
time. For some individuals it implies autonomy, empowerment, capability, and choice;
for others, security, social integration? or freedom from stress or illness-
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Seq*ela (pl. sequelae) is defined as a condition following and resulting from a
disease.
Somatic features are defined as features pertaining to the body (i.e. physical,
rather than mental).
Thyrgtoxicosis is defined as a condition resulting from exposure of body tissues
to excessive levels of thyroid hormones. This may be caused by an overactive or
damaged thyroid gland or by the administration of excessive doses of thyroid hormone'
Assumptions and Limitations of the Study
The Hyperthyroidism Complaint Questionnaire (HCQ; Fahrenfort, Wilterdink,
and van der Veen, 2000; Appendix A), the questionnaire which was adapted to be used
for this study, was originally created to be used in a study which took place in the
Netherlands and was desisred specifically for Dutch speaking people with Graves'
disease- The questionnaire was urritten in Dutch and was translated to English by Dr'
Fahrenfort, s sister (Falyenfort was the primary author of the questionnaire) for use in the
present study. Though the questionnaire was translated as literally as possible, there were
certainly subtle pieces of the questionnaire which may have been lost in the translation'
In administering this survey to English speaking people in the United States, it
was possible the questions may have been interpreted differently than originally intended
for the Dutch speaking participants. In addition to the language difference' there may
also be cultural differences which could make the data from the present study dissimilar
fromthe results of the original study performedbythe authors of the HCQ. Also, since
the HCe was designed specifically for Dutch people, it was considered that specifics of
the disease may vary between the Netherlands and the United States. This is unlikely,
since the questions were specific to physical and psychological problems, rather than
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cultural issues.
As with any mailed, anonymous survey, there was the possibility that participants
may not have been entirely truthful in their responses. Individual participants may have
answered questions diflerently depending on their mood, or the way they felt physically
on the day they took the survey. In a written suruey of this type, it was suspected that
some participants may have responded in a way they believed the investigator found
appropriate. These limitations were avoided to the greatest extent possible by
encouraglng participants to answer every question with their true feelings and also by
informing participants that they could withdraw from the study at any time without
penalty. In addition, the title of the survey was designsd to avoid the tendency to be
leading; for exarnple, the title is, "Quality of Life in lndividuals with Graves' Disease"
rather than, ..Decreased Quahty of Life in Graves' Disease," This helped to ensr:re
respondents answered with their honest, 
o'gut" feelings, rather than answering in a way
they believed the investigator fowrd appropriate.
The HCe was partially retrospective (for example, "Has complaint X been
present in the past?"). The individuals were asked to reflect on something that happened
in the past and therefore, their answers may not have been entirely accurate and they may
not have fully recalled all the details. It was possible that participants may have either
exaggerated or downplayed emotionally difficult events from their past" Similarly, a
relatively minor, though none the less significant event in a person's life may have been
exaggerated or downplayed as they were asked to try to recall the event. The accuracy of
their recollections may also have been affected as the events in question became more
distant (Sonino, Girelli, Boscaro, Fallo, Busnardo, and Fava, 1993)' Given the
retrospective nature of the questionnaire, these limitations could not be avoided'
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Therefore, in reviewing the results, it was important to keep in mind that the respondents'
recollections may not have been entirely accurate.
There was a potential for sample bias in that all participants of this study were
members of the National Graves' Disease Foundation (NGDF). TypicallY, onlY those
who have been significantly impacted by their disease will seek out membership in a
supportive organization such as NGDF. Therefore, it was possible that the disease had
presented differently or more severely in this poputation than in others who did not opt to
seek out membership in NGDF. For this reason, the results obtained by this study may
not be representative of all with Graves' disease as a whole, but may only represent
members of the NGDF.
Due to time and financial limitations, it was not possible to survey a comparison
group. This would have been helpful in estahlishing a correlation between any changes
in quality of life and a diagnosis of Graves' disease. There is no guarantee that Graves'
disease was the primary or even secondary cause of any changes in quality of life that
may have been fopnd in this study. Although the HCQ did inquire about the respondents'
other diseases, it was impossible to definitively differentiate between effects of Graves'
disease and other coexisting conditions. This may have contributed to a partially false
impression of the sequelae of Graves' disease.
The researcher did have a personal interest in Graves' disease, due to the fact that
a close family member has been diagnosed with the disease. This personal interest in
Graves, disease did have the potential to bias the study. Watchirg a family member live
with a disease can be motivational in attempting to justiff that person's struggle by
comparing their situation to others with the disease. The bias that rnay have been
introduced due to this personal connection was that the researcher may have
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unintentionally (or intentionally) attempted to sway the participants' responses' This
possible bias was reduced by administering the survey by mail, in an anonymous fashion'
By administering the survey in this rnanner, respondents were not swayed by any
emotional messages which may be given offby the researcher if the interview would
have been conducted in Person.
In conclusion, Graves' disease has the potential to afflect peoples' lives in
numerous vrays. The remaining chapters wilt highlight some of the relevant information
presented by other researchers. The researcher will also describe, in detail, the
methodotogy used and the results and conclusions that were generated by this study'
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Chapter Two 
- 
Review of the Literature
There is a considerable amount of research on Graves' disease, though much of it
is contradictory and inconclusive. Studies present conflicting information regarding
topics such as the duration and severity of symptoms, adverse effects of the various
treatment modalities, impact of stress on the disease, and which aspects of the disease
affect quality of life, if any at all. The remainder of this chapter will highJight the
findings of some of the major studies inthis field, and will describe soms of the
previously determined effects that Graves' disease may have on one's quality of life.
Resemblance of Graves' Disease to Mental lllnesses
Early in the course of the disease, patients may present with symptoms also
associated with various mental illnesses. These symptoms include but are not limited to
irritability, fatigue, anxiety, ffid hopelessness- Presentation of these symptoms early in
the course of the disease, prior to the establishment of a definitive diagnosis, can lead to
an extensive and complicated list of differential diagnoses (Stern et al., 1996)- It is not
uncopmon for patients in a state of acute hyperthyroidism to experience anxiety,
depression, and other psychological distress. It appears these psychiatric symptoms do
improve somewhat with treatment (Kathol, Turner, and Delahunt, 1986), but it is not
clear if or rnfrren they will resolve (Paschke et al., 1990)-
It has been hypothesized that psychiatric symptoms and cognitive impairment
may be more intense and may persist for a longer period of time in those who have a
higher initial thyroid hormone level and a higher resulting level of thyroid toxicity
(Wallace, MacCrirunon, and Goldberg, 1980). Conversely, Trzepacz, McCue, Klein'
Levey, and Greenhouse (1988) concluded that the severity of symptoms was trnrelated to
the quantitative level of thyroid hormone. Interestingtry, although the duration and
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intensity of symptoms may be increased due to higher thyroid hormone levels, these
horrnone levels do not appear to affect the length of one's remission (Bommer et al',
l gg0). It is clear that further research is needed to reach a more solid conclusion on this
matter
patients with hyperthyroidism may suffer symptoms similar to panic attacks. For
example, individuals often experience palpitations, anxiety, and shorhress of breath
before being treated for hyperthyroidism. It has been hypothesized that these symptoms,
albeit very contmon in the early stages of hyperthyroidism, may actually be symptoms of
panic attacks. tt is unclear, however, if these panic attacks are directly related to excess
thyroid hormone or if they are panic attacks as a separate entity in themselves
(Katerndahl and Vande Creek, 1983)'
When differentiating an isolated mental health condition from psychiatric
symptoms related to Graves' disease, it is helpful for the health care provider to obtain a
detailed history from the patient regarding onset and progression of symptoms, related
symptoms (i.e. physical symptoms such as weight loss and hair or skin changes), ffid
family history, especially of mental disorders and thyroid disease- Those with
generalized anxiety disorder (GAD) for example, ffi&y often (though not always) describe
having a lifelong history of feeling anxious (Kay and Tasman, 2000, p. 406), whereas the
anxiety associated with Graves' disease is more likely to have a relatively recent onset'
A complete physical examination as well as thyroid function tests will also help to
establish the diagnosis. Compared to individuals who have mental health disorders and
normally functioning thyroids, those with Graves' disease are more tikely to experience
physical signs and symptoms such as weight loss, enlarged thyroid, proptosis, and lid lag'
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Dfficulty in RelationshiPs
Those with Graves' disease may experience problems in their personal
relationships. These problems may be due to the patients' tumultuous emotions, or to the
real or perceived lack of understanding of the disease by their loved ones. Those
experiencing hyperthyroidism may feel hyperactive and euphoric but may often
experience significant irritability and emotional lability. As a result, they may respond to
situations of even mild conflict in a manner which would ordinarily be considered
excessive for the situation (Swanson, Kelly, and McConahey, 1981)- Although the
person may be aware of their irrational thoughts and behaviors, they may feel as though
their emotions are beyond their control, leading to increased conflicts and diffrculties in
their relationships.
Fahrenfort et al. (2000) used a questionnaire to examine the long term sequelae of
hyperthyroidism. The questionnaire queried participants about their experiences with
Graves, disease, specifically relating to relationships, eyo disease, as well as soms of the
more commonly reported issues by those with Graves' disease. They found that 4I.3%
of respondents reported experiencing more frequent conflicts in their personal
relationships. They also found that 36.3%of respondents reported feeling as though
friends and family members had a lack of syrnpathy or a lack of understanding for their
disease, jl%reported a desire to avoid large gatherings and 49.8% reported problems in
their social relationships. Considering the above factors and the fact that 35% of
respondents also reported abrupt changes in moods, it is not difficult to imagine that
one, s relationships could easily suffer when one is affected by Gtaves' disease- In most
of our lives, our loved ones play a large role in enhancing our quality of life by providing
companionship and support. Support from loved ones is vital in times of struggling with
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diseases and life-changing events. Without the help of friends and family members, a
person with Graves' disease may find their struggle to be very difficult. Therefore, if
one,s relationships are decreased in their quality, qualrty of life may also be adversely
affected in a significant way-
Graves, disease can aflect many aspects of a person's life, including their
psychiatric functioning, cognitive abilities, and personality. Members of the patients'
support system may feel as though their loved one with Graves' disease is a different
person than they were prior to the disease. This can be distressing to the person with the
disease, as well as to their spouses and family members, and as a result, "significant
marital stress and conflict" may ensue (Stern et al., 1996, p. 184' A letter from the
spouse of an individual with Graves' disease explains the difficulty the spouse
experienced as his wife dealt with her disease. He explains it was very difficult to deal
with the rapidly changing moods and the broad range of emotions displayed by his wife
and that he often felt as though he did not know who his wife was because she seemed so
different than she had before becoming ilt (Stern et al., 1996)- Reading of this man's
account of his struggle with his wife's disease further supports the difficulty those with
Graves' disease can encounter in this aspect of their lives.
Problems in DailY Functioning
Those affected by Graves' disease may experience deficits in many areas of their
functioning, especially in the early stages of the disease. Studies have shown those with
hyperthyroidism experienced decreased levels of concentration (Paschke et al-o 1990),
which can lead to difficulty in completing daily tasks. They may be unable to perform in
their job at a level of functioning similarto that of their pre-disease state- In one
particular study, it was found that hyperthyroid patients ". - . were less productive during
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the day and required naps and rests" (Rockey and Griep, 1980, p. I196). This may be
due to the disrupted sleep pattems and insomnia often experienced by individuals with
Graves, disease during normal sleeping hours. In addition to their problerns with
concentration and fatigue, individuals who are hyperthyroid may experience problems
with their memory, as well as decreased ability to solve complex problems (Treepacz et
a1., 1988), all of which can impair their level of functioning.
Changes tn the Central Nervous System
The central nervous system (CNS) may undergo changes due to, or may be
adversely affected by, abnormal levels of thyroid hormone. Researchers have suggested
those who are hyperthyroid may develop psychiatric symptoms (for example, depression,
anxiety, and agitation) due to an interaction befween thyroid hormones and structures of
the CNS (Bommer et a1., 1990). Another much older study found that the "- - . CNS is
extremely sensitiveto the eflects of thyroid hormone," (Whybrow, Prange, and
Treadway , lg6g,p. 60). Effects on the CNS may be permanent, or at least long lasting
(10 years after treatment), as evidenced by abnormal electroencephalogram (EEG)
findings (such as sharp waves and peaks and a change in the level of brain activity) in
patients who were previously diagnosed as hyperthyroid (Perrild, Hansen, Arnung, Olsen,
and Danielsen, 1986). Similar conclusions were reached in another study where it
appeared that the thyroid hormone levels normalize before the brain completely returns to
its pre-disease state of functioning, evidenced by lasting cognitive deficits, decline in
psychological well-being, and EEG changes (Wallace et al., 1980).
Weight Gain Following Treatment
Many patients lose weight before their hyperthyroidism is diagnosed and treated
because t6e excess levels of thyroid hormone help to speed up their basal metabolic rate'
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Much to the dismay of several of these patients, many will gain weight in excess of their
pre-disease weight after the astivity of the thyroid has been decreased with treatment
(Dale, Daykin, Holder, Sheppard, and Franklyn,200l).A high percentage (79%) of the
236 individuals responding to a questionnaire in a study examining the effects of
treatment with radioiodine reported weight gui, as a significant problem (Berg et al.,
1 ee6).
Interestingly, factors such as the amount of weight lost before treatment was
initiated, treatment modality employed (surgery vs. radioiodine vs. antithyroid drugs),
and prior smoking habits can have an effect on the amount of weight a patient will gain
following treatment. A greater degree of weight loss prior to treatment can be a
predicting factor for weight gain following treatment (Dale et a1., 2001). This is not
surprising, because as thyroid hormone levels normalize or decrease, the metabolic rate is
also normalized or decreased and the bodies of those who have lost a great amount of
weight are simply attempting to reestablish the premorbid weight (the weight of the
patient before the disease affected their metabolic rate). Treatment modalities may have
an effect on the amount of weight gain experienced by patients. Those patients
undergoing strgery as their primary method of treatment are more likely to gain excess
weight than those who are treated with radioactive iodine. The authors of this study were
not sure as to the exact reason for the greater degree of weight gain associated with
thyroidectomy. They speculated that it might have been due to the greater incidence of
hypothyroidism in the group treated by surgery as compared to those treated by other
methods (because those with a greater degree of hypothyroidism following treatment
were also fogndto gain more weight), (Dale et a1.,2001). A patient's degree of weight
gain was shown in one study to be partially related to urhen they quit smoking. Those
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who stop smoking after receiving treatment are likely to gain more weight than those who
quit smoking prior to the initiation of treatment for hyperthyroidism (Berg et al-, 1996)'
When facing treatment options for hyperthyroidism, patients may become
concerned about the weight gain which may ensue (Dale et a1-, 2001). This may be an
important factor to consider when providers are assessing a patient's willingness to
comply with their prescribed treatment regimen. All too often, patients in today's society
are reluctant to accept a treatment modality with an adverse effect profile including
something like weight gain, which in today's society, can carry a very negative meaning-
Failing to accept the prescribed treatment regimen for hyperthyroidism may prevent a
person from gaining weight, but it can also be detrimental to theirlrealth. In situations
like these, health care providers should use their knowledge to educate their patients to
enable them to make informed decisions. Patients being treated for hyperthyroidism
should be made aware of the health risks of remaining hyperthyroid- These risks can
include excessive weight loss, on-going fatigue, osteoporosis, cardiac arrhythmias and
left ventricular hypertrophy which in turn can lead to congestive heart failure. Patients
should also be educated on methods of avoiding excessive weight gain, including
exercising and eating a healthy, balanced diet'
Ophthalmopatlry
There are many changes that can take place in the eyes of a person with Graves'
disease (termed Graves' ophthalmopathy). Such changes include proptosis (downward
displacement of the eyeball), exopthalmos (protrusion of the eyeball), periorbital
swelling, double vision, and loss of sight. Graves' ophthalmopathy (Go) is often much
more than a physical problem to those who are affected by it- Go can affect numerous
aspects of aperson's life, such as job performance and social activities. The symptoms
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of GO are often more bothersome to Graves' patients than their other thyroid-related
symptoms (Ljunggren et al,, 1998). Not surprisingly, the changes to one's eyes not only
interfere with their ability to firnction, but can also have a drastic effect on well-being and
quality of life (Gerding et al., lggl,Krassas and Heufelder,200l, Ljunggen et al-, 1998)'
This may be due to the fact that the eyes are usually the first thing we notice when
looking at another person. Therefore, a disfiguring condition of the eyes can have a large
impact on a Person's self-image.
Studies have shown the chance of developing ophthalmopathy is positively
correlated with higher levels of thyroid hormone during the phase prior to treatment of
the disease. In addition, those treated with radioactive iodine had.a greater number of
problems with their eyes than those treated with surgery or anti-thyroid drugs (Ljunggren
et al., lggg). The evidence is irreonclusive however, as other studiesmaintainthere is no
worsening of ophthalmopathy with radioiodine (segers et al-, 1993).
Re s idual C ompl aint s aft er A c hiev ing Euthyr oidi sm
Individuals treated for hyperthyroidism may find the severity of their symptoms
diminished after reaching a state of euthyroidism and perhaps shortly after treatrnent has
been initiated, even before the hormone levels have normalized (Paschke et al-, 1990).
Unfortunately for these patients, though the symptoms may be redused in severity, they
can persist long after remission of the disease and establishment of a state of
euthyroidism (Fahrenfort et al., 2000, Berg et al', 1996).
A study examining neuropsychiatric complaints in patients with Graves' disease
found that although th* study participants did feel their level of cognitive functioning
improved after receiving treatment, they did not feel they were functioning as well as
they had before the disease process began (Stern et al., 1996). Similarly, previously
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hyperthyroid patients also appeared to decline in their intellectual firnctioning, compared
to their intellectual capabilities in their pre-disease state. Variations in pre-morbid and
post-treatment intellectual capabilities were detected by interviewing the patients about
their pre-morbid intellectual, educational, and occupational situation and comparing these
interview results with the results of post-treatment neuropsychological tests assessing
areas such as word association, story recall, picture recall, and reading- When compared
with control groups' 23% of those who had been previously hyperthyroid were found to
have .,marked intellecfual impairmeflt" while none in the control Soup had any noted
intellestual impairment (Perrild et a1., 1986).
In order to investigate the presence and severity of psychopathological and
neuropsychological symptoms in patients with remiffed hyperthyroidism, Bommer et al.
conducted a study in which euthyroid patients who were once hyperthyroid were
compared to a control S.oup with no history of thyroid abnormalities. The researchers
used several tests and questionnaires to assess for symptoms such as depression, hostility,
anxiety, sleep disturbances, and fatigue. Compared with the control group, those patients
who were previously hyperthyroid had higher scores (in other words, higher incidence of
the assessed symptoms) in areas of depression, anxiety, hostility, ffid mania than those in
the control group. However, anxiety was the only symptom that was statistically greater
in the previously hyperthyroid participants than in the control group (Bommer et al.,
1 eeO).
A study focusing specifically on Graves' ophthalmopathy (GO) found negative
effects on quality of life and atributed those effects solely to the ophthalmopathy. The
researchers used a general health survey to compare healthy adults and patients with GO.
The survey examined areas such as physical functioning, soeial functioning, mental
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health, and health perception. Analysis of their results revealed patients with GO scoring
6 to 2g points lower on the survey than the healthy adults. After reviewing their results,
the authors reasoned that because the GO patients being studied were now euthyroid, they
were not likely to be experiencing residual effects from their previously elevated thyroid
hormone levels and any effects they were experiencing were therefore due to their
ophthalmopathy (Gerding et al., lgg7), A review of some of the major studies on
hyperthyroidism revealed that achieving euthyroidism does not guarantee a return to a
pre-disease state of health and quality of life (Berg et a1-, 1996, Bommer et al', 1990,
Fahrenfort et a1.,2000, perrild et al., 19g6, wallace et al., 1980). The participants of
Gerding,s study may indeed have experienced a negative impact on their quality of life
due at least in part to their GO. Conside.ing the other sfudies done on the topic of
hyperthyroidism however, it is an illogical assumption to discount other non-
ophthalmologic aspects of Graves' disease as possible contributing factors in their
decreased quality of life simply because blood analyses reveal normal thyroid hormone
levels.
Impact of Stress on the Disesse
Though not related specifically to this study, it is important to discuss the impact
of stress on Graves' disease. Although the evidence on the topic is contradictory and
inconclusive (sonino et al., 1gg3), it is often thought that stressful events, such as a
change in employment stafus or career, death of a spouse, and pregnancy can precipitate a
hyperthyroid condition. Evidence shows that those under significant stress during the
year preceding the onset of symptoms of Graves' disease became hypothyroid earlier
after treatment with radioiodine than those who were not under stress during the year
before their disease. The proposed mechanism is that stress may contribute to the
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autoimmune reaction that is already taking place against the thyroid, and when combined
with radioiodine, the two effects are potentiated, thus causing stressed individuals to
reach a state of hypothyroidism more quickly than non-stressed individuals (Stewart,
Rochon, Lenfestey, and Wise, l9S5). Keeping in mind that the damage incurred by
radiation is dose dependent (Segers et a1., 1 993), it may be important for the practitioner
providing treatment to also consider the patient's pre-disease exposure to stress when
determining the appropriate dose of radioiodine in order to avoid a sudden shift to
hypothyroidism.
Summary
In conclusion, a review of the literature revealed many aspects of Graves' disease
which could affect a patient's quality of life. By using a written questionnaire, the
researcher was able to contact a relatively large group of individuals with Graves' disease
in order to address mafly of these aspects of Graves' disease and attempted to determine
effects on the quatity of life of the person living with the disease. The present study also
attempted, either directly or indirectly, to contribute new information to many areas of
research that have previously been disagreed upon, including persistence of symptoms
into euthyroidism, the presence of psychiatric symptoms, and the effect of non-
ophthalmologic factors on patients' quality of life.
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Chapter Three - MethodologY
D e s cr ipt ion of Me thodol o g,t
This was a descriptive, quantitative study. Because quality of life itself is
qualitative and subjective, it was difficult to ascertain exactly how, if at all, the disease
had affected the respondents' lives in a quantitative manner. In an attempt to examine
quahty of life in individuals with Graves' disease, a survey was administered to people
who had previously been diagnosed with Graves' disease. The survey addressed areas
including work, private life, and various physical components of Graves' disease' In a
study of this manner, a survey was an appropriate method for collecting a great deal of
information from many participants. The goal of using a survey to collect data for the
present study was to establish how corrmonly and/or how severely those with Graves'
disease experienced changes in their quality of life in the months prior to and in the years
following their diagnosis.
Much of the data collected was ordinal data though the demographic information
was largely nominal data. For analysis purposes, the dependent variable was defined as
the aggregate score of the complaints reported by participants in Section III of the
questionnaire. The independent variable was defined as the individual responses given to
each of the 31 complaints in Section III of the final modified surusy (See Appendix B)'
The study focused on determining how the participarrts perceived their disease and its
affect on their qualitY of life.
Design of the StudY
The questionnaire used was anonymolrs and retrospective. Most questions in the
survey were asked in a manner such that the respondents' answers could be analyzed in a
quantitative manner, even though quality of life is qualitative. The survey also contained
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an open-ended question in which the participants were asked to write in their own answer
if they experienced problems or symptoms not specifically mentioned in the
questionnaire.
Sample and PoPulation
The population of this study was the 565 active members of the NGDF. In order
to have statistically significant data for any population, at least l% of the population must
respond to the questionnaire. Written surveys usually generate a response rate of
approximately 30%. Keeping the above percentages in mind, the researcher randomly
selected 1 13 of the 565 NGDF members to receive the survey. Assuming the anticipated
30% response rate, 60/o ofthis population (34 of 565 members) would have participated'
A greater sample size than perhaps was needed was targeted because of the possibility
that not all receiving the survey would have Graves' disease. Because the NGDF is open
not only to people with Graves' disease, but also to their family members and health care
providers, recipients of the survey were asked to participate only if they had Graves'
Disease.
The population of interest for this particular study consisted of the active
mernbers of the NGDF, rather than all individuals in the United States with Graves'
disease. As a point of interest, one can consider the astual percentage of the nationwide
population of those with Graves' disease which may have been inadvertently sampled by
performing this study. According to the United States Census Bureau, the population of
the United States in the year 2000 was approximately 280 million (United States Census
Bureau, Z00Z,p. 2). As was mentioned previously, Graves' disease affects less than
t/1000 people (or less than 280,000 people) in the United States (I{GDF,2000).
Considering these numbers in conjunction with the proportion of NGDF members which
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were surveyed, the present study anticipated inadvertently sampling approximately
1110,000 individuals (34 of 280,000) with Graves', disease in the tlnited states- This was
less than the l% sample needed for statistically significant data for a population'
Therefore, the results of this study were generalized only to the members of the NGDF,
rather than to all individuals in the United States with Graves' disease.
The members of the NGDF were selected as the population of interest for this
sfudy because the foundation is a national organization, Focusing at a national level gave
more generalized information about individuals with Graves' disease in the United States,
rather than just those in Minnesota or in the Midwest. A letter requesting permission to
sl*vey this population was sent to the director of the foundation, Nancy Hord-Patterson,
phD (Appendix C). ln return, Dr. Patterson sent a letter formally granting the researcher
permission to survey the members of the NGDF (Appendix D). In addition, permission
to perform this study was granted by the Augsburg College tnstitutional Research Board
(IRB; Appendix E).
Instrumentation
As previously mentioned, the survey that was used was a slightly modified and
abbreviated version (Appendix B) of a questionnaire entitled the Hyperthyroidism
Complaint euestionnaire (HCQ). It was designed in its original forrr by Fahrenfort and
Wilterdink. The authors used the questionnaire in a study entitled, "Long-term residual
complaints and psychosocial sequelae after remission of hyperthyroidism" published in
the February 2000 issue of PsychoneuroendocrinoloU,volume 25, issue 2, pages 201'
I l. .oThe Hyperthyroidism Complaint Questionnaire (HCQ) is designed by the auttrors to
quantiff the somatic and mental discomfort that is typical for patients suffering from
hyperthyroidism" (Fahrenfort et al., 2000, p' 203)'
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Certain questions were removed from the original version of the questionnaire for
use in this study. The original questionnaire contained a rather extensive section
questioning participants on ophthalmologic complaints. For the pu{poses of this study,
the researcher was interested in learning more about the effects on quahty of life by
factors other than ophthalmologic complaints. If the participants felt strongly about their
eye complaints, there was a section in the modified version of the questionnaire which
allowed them to write in any effects they may have experienced which were not
specifically mentioned in the questionnaire-
This questionnaire was chosen because rather than focusing solely on the
cornmon physical complaints associated with Graves' disease, it addresses somatic and
mental complaints; complaints that when persistent, are suspected to significantly affect a
person,s quality of life. The survey is partially composed of a list of 31 complaints (such
as changing moods or lack of concentration, for example) and respondents were asked to
indicate whether the complaint was cwrently present, formerly present, or never present.
The HCe also gathered information on things such as the duration of the disease, how the
disease had affected the participants' relationships, and how their ability to function in
daily tife had changed since the onset of their disease.
Data Collection
Labels containing the names and addresses of the 565 active members of the
NGDF were mailed to the researcher from the office of the NGDF, with the
understanding that the labels were to be used for research purposes only and those that
were not affixed to questionnaires being sent in the rnail would be discarded immediately
after a process of random selection had taken place. Participants were randomly chosen
by selecting every fifth address label until I 13 strrvey-containing envelopes had been
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addressed. The questionnaires were then mailed on July 1 l, 2003 to those randomly
selected, along with a consent letter (Appendix F), which described the purpose of the
study and detailed the risks and benefits of participation. The letter clearly stated the
voluntary nature of participation in the study, and participants were informed of their
right to withdraw from the study at any time without consequence to their relationship
with the NGDF or Augsburg College.
Respondents were instructed that after completing the surl/ey, they were to return
the completed questionnaire to the investigator in a postage-paid return envelope which
was provided in the envelope in which they originally received the survey materials.
Respondents were informed they were not to put their names or retrun addresses on the
return envelope, ffi this was an anonymou$ survey. As a precautioilary measure however,
the returned surveys were opened by a third party (who signed a confidentiality
agreement 
- 
Appendix G) in the event that a participant may have included any
identifoing data. At the conclusion of the data collection period, Mtfl from all returned
questionnaires was entered into the Statistical Package for the Social Sciences (SPSS)
computer software program, a quantitative statistical analysis package, ffid was analyzed
in the following manner.
Data Analysis
Most of the data collected by this study was ordinal data. After the data had been
collected and entered into the SPSS software program, it was analyzed using descriptive
statistics and the percentage of respondents responding positively or negatively to each of
the items on the questionnaire. Based on the participants' responses, the researcher
looked for any identifiable trends. Inferential statistics were then used based on the
identified trends and generalizations about the members of the NGDF were then made.
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Fahrenfort et al. (2000) chose to analyze the section on residual complaints
(Appendix A; pp. 54-57) in part by using Pearson's correlation coefficient- By using this
method, they were able to identifu the degree of correlation befween the sum of all
complaints and each individual complaint. For comparison purposes, the same type of
analysis was used in the present study. In addition, Pearson's correlation was used as a
method of analysis because with ordinal data, it is an appropriate tool to use to compare
dependent and independent variables in order to identify the presence and degree of
correlation effects of variables. For this particular sfudy, statistical significance was
defined as a p value of less than 0.01'
By giving respondents an opportunity to answer questions in an open-ended
maruler, it was possible to identiff affects on their quality of life that were not otherwise
mentioned in the questionnaire. Answers to the open-ended questions were analyzed by
looking for common trends in the reported answers. If common trends were identified,
the percentages of the corrmon responses were calculated.
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Chapter Four 
- 
Results
This chapter will review the results obtained by administering the questionnaire to
the members of the NGDF.
General Information and Demographic s
Of the l13 questionnaires thatwere mailed out,79 were returned (69.9%). One
questionnaire was unusable because the respondent indicated she had never been
diaguosed with or treated for hyperthyroidism. Despite a statement in the questionnaire
instructing only those who had been treated for hyperthyroidism to complete the survsy,
the respondent completed and returned the survey but the results were obviously not
applicable to those vrith Graves' disease.
The questionnaires were mailed to the participants on July 11, 2003- The
researcher did not specift a return date when distributing the questionnaires to the
respondents. In orderto facilitate timely analysis of the dflWan arbitrary retum date of
August I l, 2003 was calculated by allowing five days postal transit time to the recipients,
two weeks for completion of the questionnaire by the participants, and five days of postal
transit time from the participants back to the researcher. An additional seven days was
added to this time period to account for miscellaneous factors that might slow the
participants from completing the flrrveys (for example, summer vacations, having the
children home for the surnmer, etc.). All surveys (eight total) received after August 11,
2003 were discarded turoPened.
After excluding the aforementioned questionnaires, 70 usable questionnaires
rernained, giving a response rate of 6l .gYo,well above the anticipated rate of 3O%. This
proportion of respondents represents 12.4o/o of the NGDF 565 active member population,
also well above the 1o4 required to achieve statistically significant data. The percentage
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of respondents who were female was 9l .4% (n- 64) while 8.6% were male (n : 6)' In
the original study by Fahrenfort et al. (2000), 87% of respondents were females.
The percentage of respondents reporting a diagnosis of Graves' disease was
9g.6% (n:69) whil e l.4Yoreported having another form of hyperttryroidism (n: l).
The majority of respondents (65.7%)were diagnosed within six months of first noticing
symptoms of Graves' disease,Z}Yowsre diagnosed seven to twelve months after the
onset of sympto ms, 2.9o/o were diagnosed 1 3- 1 I months after symptoms began, l -4%
were diagnose d lg-24 months after first noticing symptoms and 7 .Lyo were diagnosed
more than two years after their symptoms began. When asked about treatment
modalities, 6l .4o/o ofrespondents reported having radioactive iodile (RAI) treatment for
ablation of the thyroid (n: 43),7.1% of respondents reported having thyroid surgery (n =
5) and g1.g%reported they were currently being treated with a thyroid regulating
medication. The most commonly used thyroid regulating medication was levothyroxine,
with gl.0% of those responding reporting current levothyroxine use. Of those responding
to the question , 93.Zyo(n : 55) believed their thyroid was functioning well with the aid
of medication, while g3.lo/a ofrespondents (n : 54) reported their thyroids do not
function well without medication.
Residual Complaints in Individuals with Graves' Disease
In order to determine the prevalence and persistence of certain complaints (for
example, lack of energy) in individuals who have been treated for hyperthyroidism,
participants were asked to respond at the time they completed the questionnaire whether
the complaint was still presen! if it was present at some time but was no longer hthering
them, or finally, if they had never been bothered by that particular complaint- These
responses were then coded by the researcher (0 : never, l: used to bother them or 2 :
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yes, the complaint was still bothering them). Participants were asked to respond to 31
complaints, giving a maximum score of 6? for this portion of the questionnaire (if each of
the 31 complaints were still bothering the respondent, they would score aZfcr each
response and therefore, score a total of 62). The mean aggregate residual score for both
males and females was 33.6 (SD: 12.7;n:70). The mean score for womenwas 34-0
(SD: 13.2;n 
- 
64) and the mean score for men was 29.2 (SD : 5.5; n - 6)' The
dependent variable, as explained in chapter three, was the fltm of these residual
complaints.
The complaint that was rnost cofitmonly reported as still present at the time of the
questionnaire was feeting easily stressed {57.1%; n : 40). Other complaints that were
frequently reported as still being present were memory dfficulties (5l.4Vo; n : 36), lack
of energt (50-0%; n: 35), loss of libido $5.6%;n: 34), abnormally quicHy tired by
exertion (45.7%; n: 32), and lack of concentration (45.7o/o; n : 32). The least common
residual complaint reported was weight /oss (1 .4o/o; n : 1). Other ffiequently reported
residual complaints include d trembling hands Oa3%; n : I 0), iwegular menstruation
$ay%;n: l0),and heartpalpitations(l7.1o/r;n- l2). Theseindividualitemswerethe
independent variables for analysis purposes-
Table I lists each of the 31 complaints and details the percentage of the
respondents that indicated they were still bothered by each of the complaints at the time
of the questionnaire. The table also lists Pearson's correlation coefficient for each item
compared to the aggregate score of all complaints. The correlation coefficients ranged
from .l 14 to .68g with a mean of .5287. All were found to be statistically significant
$<0.01) except weight loss and excessive perspiration.
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Table 1.
Residual complaints and their correlations with the aggregate residual score
*Not statistically significant at the p<0.01 level.
Impact of Graves' Disease on Relationships
When asked if their disease had a detrimental affect on their personal
relationships (for example, with their spouse, children, close friends or family rnembers),
Complaint Correlation Coefficient Percentage of resPondents
still hothered hY
complaint 
-
Lack of .609 50.0
tired exertion
levels
.636 45.7
685 42.9
Gro .635 28.6
Heat intolerance .376 4t.4
w loss+ .l 14 1.4
hands .483 14.3
Excessive {< .2s9 20.0
Muscle aches 625 40.0
Weak muscles .538 40.0
Neck stiffiress .471 32.9
Heart .394 I 7 I
Paintul ints 600 3l .4
menstruation .396 14.3
Loss of libido .616 48.6
Insomnia .375 32.9
.688 40.0
Panic or .51 I 32.9
Abnormal need for .48 r 30.0
diffrculties 607 51.4
Sound .462 38.6
Not like usual self 65e 44.3
Irrational mood .652 30.0
F easil stressed 624 57.1
Lack of concentration .689 45.7
Over-emotional reactions 680 42.9
to relax .561 41.4
Great need for rest 493 41.4
Avoidance of .52r 40.0
F constantl rushed .397 41.4
Unable to think .677 37.t
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ZS.1%of respondents (n : l8) admitted that their relationships were still suffering as a
result of their disease and 3l.4yoof respondents (n: 22) reported that their relationships
suffered initially, but were no longer being affected detrimentally by their disease- In
total, 57 .l% of all respondents (n : 40) reported that their relationships had been
detrimentally affected by their disease at some point while 42.9% of respondents (n: 30)
reported that their disease never had a detrimental affect on their relationships. See
Figure l.
Figure 1. Responses to the question
"Did your disease have a detrimental
affect on your relationshiPs?"
E Yes, still (25.7%)
n Initially, but not
anymore (31.4olo)
I No (42.9o/o)
When questioned specifically about how their relationships had been affected,
4l .4% of respondents (n : 29) reported having more frequent conflicts since the onset of
their disease while 58.6% of respondents (n:41) did not experience rnore conflicts,
4g.6%of participants (n : 34) reported a sense that others have no understanding for their
feelings since the onset of their disease, 3l .4o/o (n : 22) rcported feeling as though their
loved onss lacked interest in their disease, 5.7% of respondents (n:4) reported going
through a divorce since the onset of their disease and 21 .4Yo (n- 15) broke off contacts
with friends and family members-
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Impact of the Disease on Career and Daily Functioning
participants were asked a question which attempted to determine how their work
lives changed following their disease. They were told to circle all options that applied.
The percentage of participants who reported that they did not change their work habits or
content as a result of the disease was 47.1% (n - 33). Five of the respondents (7.1%)
reported stopping work completely because of their Graves' disease,20yo of respondents
(n: 14) stopped working temporarily but then resumed work completely,T -1% (n * 5)
reported a change in the content of their work, 17 .l% (n : 12) reported working fewer
hours as a result of their disease while 7 .I% of respondents (n : 5) retired as a result of
their illness. Only 2 respondents reported being declared completely disabled because of
Graves, disease. When asked how their disease had impacted their ability to do
housewo rk, 35.7o/o of respondents believed themselves to be less able than before the
onset of their illness. A small percentage (5 .7%) reported it to be almost impossible to do
what they used to consider normal work. See Figure 2.
Figure 2. Responses to the question'
"Are you less able to do house work
hecause of your ffrYroid Problem?"
u I am as able as bebre
(58.6%)
t I am less able than
before (35.7Yo)
n lt is almost impossible
to perfrrrm what I used
to consider normal
work (5.7%)
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S/ress and a Possible Connection to the Development of Graves' Disease
participants were asked whether their first complaints of Graves' disease occurred
during an extraordinary period in their lives. Possible responses included the following:
pregnancy, busier than usual, an emotionally difficult time period or nothing out of the
ordinary. participants lryere told to circle all that applied. OnIy 2 respondents (2.9%)
experienced their first thyroid complaints during pregnancy,35.7 % (n :25) reported
they noticed their f,6st complaints during a particularly busy time during their lives,
4g.6%(n : 34) of the participants first noticed their symptoms during an emotionally
difficult time in their lives and 34.3% (n - 24) reported there was nothing out of the
ordinary going on in their lives when they fust noticed their Graves' disease symptoms'
Symptoms Resembting Various Forms of Mental lllness
The percentage of respondents who reported seeking psychological help for their
problems since the onset of their disease was 22.9o/o {n: l6) whereas 18.6% (n: l3)
reported feeling the need for psychological help, but did not act on that feeling. The
majority of participants (75.7%;n : 53) reported experiencing depression at some point
since the onset of their disease. The questionnaire also asked about specific symptoms
which may or may not be symptoms of depression. Responses to those symptoms
possibly related to depression were as follows: 81.4% of participants (n: 57) reported
feeling a lack of energy at some point since their diagnosis,82.9o/o (n: 58) experienced
irrational mood changes ,84.3ya (n : 59) had difficulty concenffating and 72-9Yo af
participants (n: 53) felt feelings of panic or anxiety during since their illness began. See
Figrre 3.
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Figure 3. Proportion of respondents
experiencing symPtoms mimickin g
depression and ofrter mental illness
INo
n Yes
Complaints I,lot Specrfically Addressed in the Questionnaire
At the end of the questionnaire, participants were given the opportunity to
mention any complaints that they may have experienced that were not mentioned in the
questionnaire. Several of the participants (52.9%; n: 37) took that opportunity. The
rnost corlmon theme brought up hy participants dealt with eye complaints. Fifteen of the
respondents mentioned some fype of eye or vision problem iu the section allowing them
to freely write comments. Although some individuals simply indicated they had "eye
problems," others indicated what type of eye problems they had experienced- Some of
the more commonly mentioned problems include blurred or double vision, proptosis, dry
eyes, Iight sensitivity and painful eyes-
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Chapter Five * Discussion
Implications
Considering that 93% of respondents believed themselves to be euthyroid, one
can examine the results of this study and determine that Graves' disease does have lasting
effects on those who carry this diagnosis, at least to members of the NGDF; effects that
persist evefl when individuals consider themselves to be euthyroid. Althougfu they
considered themselves to be euthyroid, a good proportion of participants continued to
experience many of the complaints inquired about in this study, as well as in the original
study by Fahrenfort et al (2000). Table 2 illustrates some of the more cofilmonly reported
residual complaints in this study, as well as those that were not commonly reported,
compared with the results of the original study. The reason for the variation benareen the
two populations was unknown, but may possibly have been due to the fact that subjects
of the current study were members of the NGDF, and as mentioned in chapter one, there
was a possible sample bias involved in choosing subjects all belonging to a support
organization of this ffie. Another possible cause for this difference, other than charrce
alone, is the possibility that subtle changes in the nreaning of the questions may have
occurred when the questionnaire was translated from Dutch to English.
Table 2 also illushates the correlation coefficients of those reported complaints.
Of all the cornplaints listed in the table, the complaint with the highest correlation
coeffrcient was gufckly exhausted (r: .636). Thus, as individuals reported feeling more
quickly exhausted, the aggregate score of the residual complaints increased. Correlations
greaterthfln 0.7 are considered high, those in the range of 0.3 to 0.7 in general are
considered to be moderate, and those less than 0.3 are considered weak. Most of the
correlations in this study were found to be in the moderate range.
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Table 2. Comparison of the most commonly and least comrtronly reported residual
in this with from the
With regard to the impact of Graves' disease on relationships, both similarities
and differences can be seen between the present study and the original study by
Fahrenfort et al. In the present study, while a total of 57.1% of participants reported their
disease had a detrimental effect on their relationships at some point during their illness,
31.4%reported that this was only a problem initially. In the original study, although
fewer total participants reported having problems in their relationships (49.8%), the
proportion of participants (33 .1%)who felt their relationships suffered only initially was
rather similar to the present study. In the present study, 41.4% of individuals reported
having more frequent conflicts, compared with a very similar 41.3% in the original study.
4g.6%of respondents in the present study reported a feeling that their loved ones had a
lack of understanding for their feelings, compared with 36.60/0 in the original study. The
reason for the difference between these two populations is unknowru but again, may be
explained by a population bias and a change in meaning dwing translation of the study.
Clinicians caring for patients with Graves' disease should take these results into
consideration in their treatment plan. In caring for a patient with Graves' disease, the
clinician should make attempts to involve the family in the patient's care and to enhance
Original Study by
Fahrenfort et al. (2000)
Present Study
Correlation
Coefficient (r)
PercentageCorrelation
Coefificient (r)
Percentage
Complaint
.6244.62457 .tEasily Stressed
.49396075r.4Memory Difficulties
.604060950.0Lack of Enetff_
.4232.61648.6Loss of Libido
7045
.6364s.7Exhausted
15 .50.394t7.rHeart Palpitatioq!_
.34l548314,3Trembling Hat4q_
239.39614.3Irregular Menstruqllg!_
Quatity of Life 37
the loved ones' understanding of the impact of this disease on the patient. By involving
and educating loved ones, perhaps clinicians can help improve the feelings of isolation
that these patients sometimes experience.
As described in chapter two, past studies (Rockey and Griep, 1980, Trzepacz et
al., l98S) have shown that individuals have difficulty in ttreir daily functioning for
various reasons including fatigue, difficulty with concentation, and memory impairrnent.
Although participants in the present study were asked ftheir ability to firnction was
impaired, they were not askedwhy they believed their ability to function had declined, if
they responded affirmatively to the question. Individuals responding to this study did
report being less able to do their regular housework (35.7%) but npt to the degree
reported by Fahrenfort et al. (62.30/o).
Studies have shown that there are often symptoms present early on in the corrse
of Graves' disease (and sometimes even persisting long after treatment) that may mimic
psychologcal disorders, such as depression or anxiety (Stern et al., 1996, Kathol et a1.,
1986, Paschke etal., 1990). Results fromthis study axe consistentwiththe findings of
those earlier studies. Symptoms that may appear in patients with depression and/or
anxiety can include insomni4 fatigue, depressed mood, difficulty coilcentrating, panic or
anxious feeling, mood swings and irritability or over-emotional reactiorts. See Table I
for the percentages of respondents still experiencing these symptorns. Some of these
symptoms did improve as the disease progressed (insomnia panic and mood swings),
whereas others either persisted or worsened during the course of the disease (depression,
fatigue, difiiculty concenffiting, irritability). When considering the prevalence of these
symptoms cofiunonly found in depression and other mental illnesses, it is understandable
that the picture of Graves' disease is often clouded early on in the illness, especially prior
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to doing any laboratory studies. These results help support the need for a strong support
system for these patients, including involvement of loved ores, as well as referral for
counseling services where appropriate. Anti-depressant or anxiolytrc therapy should also
be considered if symptoms persist despite achieving and maintaining euthyroidism. It is
important not to ignore the psychological symptoms associated with Graves' disease. "A
severe shortcoming of regular medical attention provided for hyperthyroid patients is that
psychologrcal problems are frequently ignored because of the traditional division of tasks
in care," (Fahrenfort et al., 2000, p. 210)-
Though participants were not questioned specifically about ophthalmopathy, 15
respondents (21 .4%) took the opportunity to mention some form of ophthalmopathy as a
persistent problem in the free-writing section at the end of the questionnaire. One female
respondent wrote, "Eyes bulged before decompression surgery - I felt like some weird
thing 
- 
physical beauty was threatened 
- 
very self conscious." Another wrote in regards
to her ophthalmoputtry, "This has affected my work and activities far more than my
hyperttryroidism." The results of this study support earlier studies which found that
individuals with ophthalmopathy often find their symptoms exhemely bothersome and
may find their sense of well-being adversely affected as a result of the disfiguring effects
caused by ophthalmopathy (Ljunggren et al., 1998, Gerding et al., L997, Krassas and
Heufelder, 2001).
Fortunately, the majority (65.7%) of participants of this study were diagnosed
with Graves' disease relatively soon after first noticing their symptoms (within the frst
six months). However, there were also 3 1.4% who were diagnosed seven months or
more after the onset of their symptoms. There are several possible explanations for this
delay in diagnosis. One possible reason is that as mentioned above, the diagnosis of
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Graves' disease is often clouded by other symptoms early on. Another possible
explanation is that not all individuals in this country go to their physician's office for
routine health care and may not even go when something is wrong.
Limitations
With 17.4% of the members of the NGDF being represented in this study, the
results are easily generalized to this population, as only 1% is necessary to allow
generalization to a particular population. However, assuming there are 280,000
individuals in America with Graves' disease (see chapter three - Sample and
population), this study sampled far less than the I % of individuals with Graves' disease
in the U.S. Therefore, this data can be generalized to the membsrs of the NGDF, but not
to all in the U.S. with Graves' disease.
The sample size of this study could have been slightly greater if the researcher
had specified a return date on the questionnaires. An arbitrary return date was set for
August t l, 2003 and all surveys received after this date \ryere discarded, as described in
chapter four, However, the rcsearcher continued to receive completed surueys even as
late as January 2004. If a return date had been specified, perhaps more individuals would
have returned their questionnaires in a more timely manner.
A great limitation of this study was that the age of participants and their age at
diagnosis was not confirmed. Therefore, the researcher was unable to determine the
duration of illness in the respondents. Without knowing how long the participants have
been affected by Graves' disease, the researcher was unable to determine any long lasting
effests of the disease. Certainlyo this is key inforrration for a study of this type and
unfortunately, it was removed from this sfudy due to an oversight.
Unfortunately, very few men responded to the questionnaire (8.6% of
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respondents, or n: 6 were male). This was not entirely surprising, considering that
Graves' disease is known to be much more prevalent in women than in men" Although
the researcher did comprue mean aggregflte residual scores between males and females,
other more extensive analyses were not done to compare responses between males and
fernales.
Discussion
Graves' disease affects many areas of ones life, as evidenced bythis study. Those
affected by the disease may experiense mood disturbances, relationship difficulties,
decline in'normal'daily functioning, and physicat deformities, especially of the eyes.
This list is not exhaustive and it is importarrt for clinicians to recognize that Graves'
disease affects more than just the thyroid. Quality of life is made up of many
cornponents and is a subjective idea that may be afflected in various ways from one
individual to another, even if they are aflected by their disease in the same way. By
reviewing the definition of quatity of life as defined in chapter one, it seems obvious that
a disease that affects individuals in areas such as physical appearance, fatigue, and daily
functioning can indeed have a significant impact on quality of life.
This study and past studies concluded that the qualrty of life of individuals with
Graves' disease is at times dramatically affected by this distessing disease. Perhaps one
of the best things clinicians can do as a service to their patients is to educate themselves
about Graves' disease and how it affects those with the disease, As one respondent wrcte
in her questionnaireo "They (doctors) don't uuderstand my complaints or conceffIs- They
don't understand or know Graves' disease ." We also need to maintain a heightened
index of suspicion and do diagnostic testing where clinically indicated, as well as
perforrring regular screening tests periodically (screening is done most easily and most
Quality of Life 41
cost-effectively by testing thyrotropin-stimulating hormone (TSH)).
Recommendattons
If this research project, or similar projects, were to be completed again, there are
certain steps that could be taken to make the data more meaningful. Although sampling
the NGDF members was a simple way to reach a relatively large group of individuals
with Gpaves' disease, the data cannot necessarily be generalized to all with Graves'
disease because, as was previously mentioned in chapter one, individuals often only join
a support group if their experience has had a significant impact on their life. Any disease
affects difterent individuals in varying degrees. tt is impossible to determine whether or
not the members of the NGDF were more adversely affected by their disease without
doing a comparison study u/ith nonmsmbers.
In adapting the original questionnaire designed by Fahrenfort et al. (2000) for
distribution to the participants in the present study, two questions were inadvertently
removed that would have been helpful in data analysis. A question regarding the
duration of the disease was one of the questions that was inadvertently removed. \Mithout
this question, we have no way of knowing whether the participants were diagnosed last
month or ten yerrs &go, for example. Knowing how long the individual has been affected
by the disease is important in determining the residual affect of their symptoms. For the
purpose of this research, it is rnuch more meaningful and significant to know that an
individual is still plagued by a particular symptom several years into their disease, rather
than two months after their diagnosis, for example. Future studies examining the topic of
quahty of life should therefore inquire about the firation of the illness.
For the ptrrposes of preserving anonymity, a question regarding age was also
removed. Although this study did not concentrate on residual affects in individuals of
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varying agss, perhaps in future studies, researchers might observe how Graves' disease
impacts patients of all ages in an attempt to determine any differences. Similarly, future
studies might discover impomant gender differences in doing a comparison between the
sexes. A larger number of male participants than the number generated by the present
study would be needed to perform analyses of this type.
Conclusions
This study concluded that although individuals may perceive themselves to be
euthyroid, they continue to be bothered by symptoms related to Graves' disease- People
\rrith Graves' disease continue to experience symptoms such as depression, fatigue,
irritability, ffid ophthalmopathy, sometirnes long after the diagnosis has been made.
Numerous other studies have rnade similar suggestions (Berg et al., t996, Bommer et a1-,
lgg0, Fatrrenfort et al., 2000, Paschke et al., 1990, Perrild et al., 1986, Steru et a1', 1996,
Trzepacz et al., lgBB, Wallace et aI., l9S0). Knowing these findings, clinicians caring for
patients with Graves' disease should work to support their patients by offering resources
such as referrals to local and national support groups (such as the National Graves'
Disease Foundation) and counselors. Symptoms, including psychological symptoms,
should not be ignored and should be treated accordingly. One clinician needs to act as
the primary coordinator of care in each patient's case to ensure that all aspects of the
patient,s disease are being addressed. By supporting these patients and acknowledging
and treating all aspects of Graves' disease, hopefully, we can play a small role in
enhancing their quality of life.
I
I
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Number of questionnaire:
BASIC QUESTIONNAIRE; TITYROID PROBLEMS
Introduction to the questionnaire
The questions concern:
The course and treatmerrt of your thyroid disease'
Possible effects on your work and private life'
Different kinds of complairt* por*ibly connected to the thyroi4 among them eye complaints'
The first part of the questionnaire can be diffrcult for some people, because.it asks for exact dates that might be
difficult fo, everyboiy to remember. This concerns questions like: 'when did the complaints start?', 'when did
the treatment start?,, .when was everything in balance again?', etc- These questions are important for the
research" Hopefully you can still lindth" in***. by looking up forms/papers or asking others- If you only know
approximate dates i.e. you have a date that is accurate within i margin of some months, the answer can still be
ur*0. tf you really do not know a date within a reasonable margin of accuracy, you should leave that answer
blank. For the other questions, you should cross or fill in only one of the alternative answers'
0
0
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1. You are:
male
female
2. Date of birth:
3. Are you, or have you ever been treated for hyperthyroidism? (i.e. a thyroid gland that works too fast)?
yes
no, never
This research concerns people who answered 'yes' to this question. If you answered 'no' to this question, you
are now finished with this questionnaire.
4. What diagnosis did your doctor provide?
Graves'disease
Another thyroid disease
don't know
5. During the past five years, have you had any other serious disease apart from your thyroid problem?
no
yes, this was:
This disease started in the Year:.
6. When was the first time you came in for treafinent for you thyroid?
Month. ......Year:
7. Many people suffered complaints connected to thethyroid long before the disease was diagnosed by a doctor'
When iia you first suffer complaints that, in hindsight" tumed out to be connected to thyroid disease?
Month Year:
8. Please describe these complaints
0
0
0
0
0
o
0
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9. The time lapse between your first complaints and the diagnosis of thyroid disease by your doctor was about:
I 
- 
6 months
7 
- 
12 months
13 
- 
l8 months
19 - 24 months
more than 24 months
Did your first complaints occur during an extraordinary period in your life?
0
0
0
0
0
10.
Pregnancy
yes
no
0
0
More than usuallY busY
0 yes
0no
An emotionally difficult period in your life
0 yes
0no
Nothing out of the ordinarY
0 yes
0no
11. Have you, or are you still using medication for regulating your thyroid?
0 yes (or yes, I still am)
0 I used to, but do not uss now -> go to question 14
0 no, I have not and do not use this kind of medicine -> go to question 14
Thyrax
yes
no
0
0
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12. What kind of medication are you using for your thyroid?
(if possible, look at the label of the box or bottle)
A- tlryroid 
- 
inhibitor:
Basolest (carbimazol)
0 yes
0no
Strumazol (methizanol)
0 yes
0no
P.T.U. (propyl-thiouracil)
0 yes
0no
B. thyroid hormone
other brand, i.e.:..
13. At present does your thyroid function well with thF aid of medication?
yes, since: month. --.Year"
no
don't know
14. At present does your thyroid function well without the aid of rnedication?
yes, since: month.. -.-.."Year'
no
don't know
15. At present does your thyroid function too fast? (i.e. do you suffer from hyperthyroidism at prtsent?)
yes
no
don't know
16. At present does your thyroid function too slow? (i.e. do you suffer from hypothyroidism at present?)
yes
no
don't know
0
0
0
0
0
0
0
0
0
0
0
0
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lT. Have you had research or treatment with radioactive iodine in connection with your thyroid complaints?
yes, but only to make an x-ray
yes, for regulating the thyroid in the rnonth.
no
don't know
18. Have you had a thyroid operation?
0 yes, operation in the month-
0no
0
0
0
0
..-year.
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WORK AND PRIVATE LIFE
lg. At the time that your first thyroid complaints started, were you working or studying?
no job
school, study, other education, militaqy
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0
0
0
servlce
paid tull-time job
paid part-time job
full-time voluntarY work
part-time voluntarY work
20. How is your situation as regards work, education at the present timq?
no job
school, study, other education, military
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
ssrvrce
housew ife/househu sband - home
paid tull-time job
paid part-time job
full-time voluntary work
part-time voluntarY work
21. Did a change take place in your work/occupation etc- on account of the thyroid disease?
no change in work on account of the illness
completely resumed work after an intemrption on,acsount of illness
the content of the work has changed on account of the illness
stopped working temporarily on account of the illness
*orkirrg less hours (for a longer period) on account of the illness
stoppeiworking completely (fora longer period) on account of the illness
22. Have you been declared (partially or completely on account of Your thYroid Problem?
yes, partially
yes, completely
no
23. Areyou less able to do house-work or other work in and around the house on account of your thyroid
problem?
0 I am as able as I was before
0 I am less able than before
0 It is almost impossible to perform what I used to consider to be normal work
24. Did your disease have a detrimental eftect on your relationships with other people in your direct
environmen! like your partner, children, intimate friends, family members?
0 yes, this is still the case
0 it used to be so at the time, but at not any more
0 no, not reallY -> Go to question 31
0
0
0
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Did you suffer from one or more of the effects below?
25. More conflicts
26. No understanding for my feelings
}7.Lackof inkrest in mY illness
28. Divorce
29. Breaking offof contactswith friends/family members
30. Other important effects:
31. Did you seek help for psychological problems since the start of the thyroid disease?
0 no, I did not need it
0 I felt the need, but have not acted upon it
0 yes, I have had (or still have) professional help for those problems
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0
0
yes
no
yes
IIo
yes
no
0
0
0
0
yes
no
0
0
yes
no
0
0
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POSSIBLE COMPLAINTS OF THYROID PATIENTS
l. Lackofenergy
yes, still the case
used to be so, not anY more
did not have that
2. Abnormally quickly tired by exertion
yes, still the case
used to be so, not anY more
did not have that
3. Energy levels changing erratically throughout the week
0 yes, still the case
0 used to be so, not anY more
0 did not have that
4. Dull feeling in the head, grogginess
yes, still the case
used to be so, not anY more
did not have that
5. Not being able to bear warm temperatures
yes, still the case
used to be so, not anY more
did not have that
6. Loss of weight
yes, still the case
used to be so, not anY more
did not have that
7. Trembling hands
yes, still the case
used to be soo not anY more
did not have that
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From interviews with patients it became clear that there are great differences between patients in the quantity,
seriousness and duration of complaints experienced. would you please indicate which complaints you suflered
from the start of the thyroid disease? Thesl questions can only be answered from your own'gut feeling'' Please
do not feel you have to be completely sure.
If a particular complaint never nom*r*A you much, you should cross 'did not have that"
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
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0
0
0
L Excessive PersPiration
yes, still the case
used to be so, not anY more
did not have that
9. Aching muscles
yes, still the case
used to be so, not anY more
did not have that
10. Weak muscles
yes, still the case
used to be so, not anY more
did not have that
11. Stiffuess in the neck
yes, still the case
used to be so, not anY more
did not have that
12. Heart palpitations
yes, still the case
used to be so, not anY more
did not have that
13. Painful joints
yes, still the case
used to be so, not anY more
did not have that
14. Irregular menstruation
yes, still the case
used to be so, not anY more
did not have that (or not applicable)
15. Loss of libido?( sex drive)
yes, still the case
used to be so, not anY more
did not have that
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
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0
0
0
0
0
0
0
0
0
16. Insomnia
yes, still the case
used to be so, not anY more
did not have that
17. Depression
yes, still the case
used to be so, not anY more
did not have that
18. Feelings of Panic or anxietY
yes, still the case
used to be so, not anY more
did not have that
19. Abnormal need for sleeP
yes, still the case
used to be so, not anY more
did not have that
20. Memory difficulties +**
yes, still the case
used to be so, not anY more
did not have that
21. HypersensitivitY to sound
yes, still the case
used to be so, not anY more
did not have that
22.The feeling of not being your usual self
yes, still the case
used to be so, not anY more
did not have that
23. Irrational mood changes
yes, still the case
used to be so, not anY more
did not have that
24. Feeling easily stressed
0 yes, still the case
0 used to be so, not anY more
0 did not have that
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
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25. La*k of concentration
yes, still the case
used to be so, not anY more
did not have that
26. Over-emotional reactions
yes, still the case
used to be so, not anY more
did not have that
27. A feeling of not being able to relax
yes, still the case
used to be so, not any more
did not have that
28, A great need to rest
yes, stillthe case
used to be so, not anY more
did not have that
29. Would rather avoid large groups of people
yes, still the case
used to be so, not any more
did not have that
30. A feeling of having to hurry all the time
yes, still the case
used to be so, not any more
did not have that
31. A feeling of not being ahle to think straight
yes, still the case
used to be so, not any more
did not have that
32- Do you suffcr from any other complaints not mentioned in this list?
no
Y9S,'
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0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
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EYE COMPLATNTS
33. Did (or do) you have eye complaints?
yes, still the case
used to be so, not anY more
did not have those
The following questions exclusively concern eye complaints. If you answered the former question with 'no',
you have finished this questionnaire-
Which complaints did (or do) you have, in one or both eyes?
34. The feeling that there is sand in my eyes
yes, still the case
used to be so, not any more
did not have that
35. Pressure in the eYe socket
yeg still the case
used to be so, not any more
did not have that
36. Pain behind the eYes
yes, still the case
used to be so, not anY more
did not have that
37. Blurred vision
yes, still the case
used to be so, not anY mort
did not have that
38. Not being able to see colours well
yes, still the case
used to be so, not anY more
did not have that
39. Watering eyes
yes, still the mse
used to be so, not anY more
did not have that
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
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0
0
0
40. Hypersensitivity to bright light
yes, still the case
used to be so, not anY more
did not have that
41. Seeing double when looking in a certain direction
yes, still the case
used to be so, not anY more
did not have that
42. Seeing double all the tirne
yes, still the case
used to be so, not anY more
did not have that
43. Difficulties with moving your eyes
yes, still the case
used to be so, not anY more
did not have that
44. Eyes that tire excessively quickly
0 yes, still the case
0 used to be so, not anY more
0 did not have that
45. Deterioration of eYe facultY
yes, still the case
used to be so, not anY more
did not have that
46. Bulging eyes
yes, still the case
used to be so, not any more
did not have that
47. Withdrawal of the eYelids
yes, still the case
used to be so, not anY more
did not have that
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
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48. Swelling of eYelids
yes, still the case
used to be so, not anY more
did not have that
49. Have your look#appearance suffered Sfeatly from your disease?
yes, still the case
used to be so, not anY more
did not have that
50. Have you suffered from any other eye complaints apart from those on this list?
no
51. Have you been treated by an ophthalmologist (eye doctor) for the complaints mentioned here?
0 yes, still under treatment
0 yes, finished at Present
0 no, not teated by an ophthalmologist
52. Did the doctor prescribe Prednisone (at the time)?
yes, I still use it
yes, I have used it
no
THANK YOU YERY MUCH FOR ANSWERING ALL THESE QI.JESTIONS!
#########.### ###### ######## ####
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0
0
0
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Instructions: For questions l-20, please circle only one of the answers, unless otherwise indicated'
Section I: DIAGNOSIS OF THYROID DISEASE
l. Are you currently being treate4 or have you ever been treated for hyperthlroidism? (i'e- a thyroid gland that works too
fasfl?
no, never
This research concems people who answered 'yes' to question #1. If you answered 'no' to this question, you are now
finished with this questionnaire-
2. If you answered yes to question #1, what diagnosis did your doctor provide?
a. Graves'disease
b. Another thyroid disease
c. don't know
3, What is your sex?
a. male
b. female
4. During the past five years, have you had any other serious disease besides your thyroid problem?
5. The time lapse between your first complaints and the diagnosis of thyroid disease by your doctor was about:
a. l-6months
b. 7-12months
c. 13 
- 
l8 months
d. 19 - ?4 months
e. more than}4 months
6. Did your first complaints occur during an extraordinary period in your life, such as ' . . (circle all that apply)'
L. Pregnancy
b. More busY than usual
c. An emotionally difficult period in your life
d. Nothing out of the ordinary
7. Have you used, or are you still using medication for regulating your thyroid?
a. yes (or yes, I still am)
b. I used to, but do not use now -) go to question 12
c. no, I have not and do not use medicine to regulate my thyroid-= go to question 12
g. ril/hat kind of medication are you using for your thyroid? (if possible, look at the label of the box or bottle)
A. thyroid 
- 
inhibitor:
Tapazole (methimazole)
a. yes
b. no
Researcher: Jennifer Gustafson
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P.T. U. (propyl-thiouracil)
a. yes
b. no
B. tlryroid hormone
Ievothyroxine
a. yes
b. no
g. At present does your thyroid function well with thq aid qf medication (i.e. are your thyroid hormone levels within
normal limits)?
a. yes
b. no
c. don't know
10. At present does your thyroid flrnction well withou! the aid of medication (i.e. are your thyroid horrrone levels within
normal limits)?
a. yes
b. no
c. donot know
I l. Have you had tests or treatment involving any radioactive iodine in connection with your thyroid complaints?
a. yes, but only for diagnostic scans or uptakes
b. yes, for abtatiou ofthe thYroid
c. no
d. don't know
12. Have you had thYroid surgery?
13. At the time that your frst thyroid complaints starte4 how would you best describe your occupation? (Circle
al[ that apply)
a. no job
b. school, study, other education, military service
c. homemaker
d. paid full-time job
e. paid part-time job
f. full-time volunteer workg. part-time volunteer work
e. retired
Researcher: Jennifer Gustafson
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Section II: WORK AND PRMTE LIFE
a.
b.
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14. How would you best describe your occupation at-the present tim-e? (Circle all that apply)
63
a. no job
b. school, study, other education, military service
c. homemaker
d. paid tull-time job
€. paid part-time job
f. full-time voluntarY work
g. parttime voluntary work
e. retired
15. Did a change take place in your work/occupation etc. because of the thyroid disease (circle all that apply)?
a. no change in work because of the illness
b. completely resumed work after an intemrption because of the illness
c. the content of the work has changed because of the illness
d. stopped working temporarily because of the illness
e. working less hours because of the illness
f. stopped working completely because of the illness
g. retired
16. Have you been declared partially or completely disabled because of your thyroid problem?
a. yes, partially disabled
b. yes, completely disabled
c. no, not disabled
1?. Are you less able to do house-work or other work in and around the house because of yow thyroid problem?
a. I am as able as I was before
b. I am less able than before
c. It is almost impossible to perform what I used to consider to be nonnal work
lg. Did your disease have a detrimental effect m your relationships with other pecple in yoru direct environment,
like your parftrer, children, intimate friends, fanrily members?
a. yes, this is still the case
b. it used to be so initially, but not any more
c. no, not really
19. Since the onset of your thyroid disease, have you experienced one or more of the effects below? (Mark all
that apply).
a. More conflicts
b. A sense that others have no understanding for your feelings
c. Lack of interest (by your loved ones) in your illness
d. Divonce
e. Breaking offof contacts with friends/family members
20. Did you seek help for psychological problems since the start of the thyroid disease?
a. no, I did not need it
b. I felt the need, but have not acted upon it
c. yes, I have had (or still have) professional help for those problems
Researcher: Jennifer Gustafson
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SCCtiON III: POSSIBLE COMPLATNTS OF THYROID PATIENTS
please indicate by circling which complaints you have experienced since t}le start of your thyroid disease' These
questions can only be answered from y"* o* 'gut feeling'. Please do not feel you have to be completely sure' If
a particurar compiaint never bothered you much, you should circle 'did not have that-'
1. Lack of energY 9' Aching muscles
a. yes, still the case
b. used to be so, not anY more
c. did not have that
10. Weak muscles
a. yes, still the case
b. used to be so, not anY more
c. did not have that
2. Abnormally quickly tired by exertion
a. yes, still the case
b. used to be so, not anY more
c. did not have that
3. Energy levels changing erratically throughout
the week
a. yes, still the case
b. used to be so, not anY more
c. did not have that
4. Dull feeling in the hea{ grogginess
a. yes, still the case
b. used to be so, not anY more
c. did not have that
5. Not being able to bear warm temperatures
a. yes, still the case
b. used to be so, not anY more
c. did not have that
6. Loss of weight
a, yes, still the case
b. used to be so, not anY more
c. did not have that
7. Trembling hands
a. yes, still the case
b. used to be so, not anY more
c. did not have that
8. Excessive PersPiration
a. yes, still the case
b. used to be so, not any more
c. did not have that
a. yes, still the case
b. used to be so, not aflY more
c. did not have that
I l. Stiffiress in the neck
a. yes, still the case
b. used to he so, not anY more
c. did not havelhat
12. Heart palpitations
a. yes, still the case
b. used to be so, not anY more
c. did not have that
13. Painful joints
a. yes, still the case
b. used to be so, not anY more
c. did not have that
I 4. Irregular menstruation
a. yes, still the case
b. used to be so, not anY more
c. did not have that (or not applicable)
15, Loss of libido? (sex drive)
a. yes, still the case
b. used to be so, not anY more
c. did not have that
Researcher: Jennifer Gustafson
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16. Insomnia
a. yes, still the case
b. used to be so, not anY more
c. did not have that
17. Depression
a. yes, still the case
b. used to be so, not anY more
c" did not have that
18. Feelings of Panic or anxietY
a. yes, still the case
b. used to be so, not anY more
c. did not have that
19. Abnormal need for sleeP
a. yes, still the case
b. used to be so, not anY more
c. did not have that
20. Memory difficulties
a. yes, still the case
b. used to be so, not anY more
c. did not have that
21. Hypersensitivity to sound
a. yes, still the case
b. used to be so, not anY more
c. did not have that
2?', The feeling of not being yolr usual self
a. yes, still the case
b. used to be so, not anY more
c. did not have that
23. lrrational mood changes
a. yes, still the case
b. used to be so, not any more
c. did not have that
25. Lack of concentration
a. yes, still the case
b. used to be so, not anY more
c. did not have that
26. Over-emotional reactions
a. yes, still the case
b. used to be so, not anY more
c. did not have that
27. A feeling of not being able to relax
a. yes, still the case
b. used to be so, not anY more
c. did not have that
28. A great need to rest
a. yes, still the case
b. used to be so, not anY more
c. did not have that
29. Avoidance of large groups of people
a. yes, still the case
b. used to be so, not anY more
c. did not have that
30. A feeling of having to hurry all the time
a. yes, still the case
b. used to be so, not anY more
c. did not have that
31. A feeling of not being able to thiilk staight
a. yes, still the case
b. used to be so, not anY more
c. did not have that
32. If you experience other complaints not
mentioned in this list, please list below:
24. Feeling easily stressed
a. yes, still the case
b. used to be so, not anY more
c. did not have that
Thank you very much for answering all these questions! You have completed the survey. Please retux it
in the stamped enveloPe Provided!
Researcher: Jennifer Gustafson
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November 20,2002
Dr. NancY Patterson
P.O. Box 1969
Brevard, NC 28712
Dear Dr, Patterson,
Jennifer Gustafson
1020 Feltl Court, #106
Minnetonka MN 55343
(esz) 988-9344
j engustafson@hotrnail . com
Hello. We have communicated over e-mail several times regarding the administration of
a survey to the active members of the National Graves Disease Foundation (NGDF) as a
part of the requirement for the completion of my master's thesis at Augsburg College in
Minneapolis, Minnesota. I am now writing to request your formal, written approval to
collect data from a portion of those members'
I understand the NGDF has a policy of not releasing the names and addresses of its
members, and NGDF would tirerefore be responsible for the addressing and mailing of
the questionnaires. I will accept fulI responsibility for the cost of printing and postage'
I have enclosed a copy of the questionnaire that I will be using- The Hyperthyroidism
Complaint euestior*rir" (HCQ) was originally written in Dutch by J.J. Fahrenfort and
A.M.L. Wilterdink for a study clmplet*d in the Netherlands. The article detailing their
results, ..Long-term residual comptaints and psychosocial sequelae after remission of
hyperthyroidlsm', can be found in the February 2000 issue of Psychoneuroendocrinolow,
Volume 25, Issue 2, pages 201 -2 t 1 . The draft of the HCQ I have enclosed is somewhat
final in that no additio"ur questions will be added. I may however omit some of the
questions. I will be certain to share a copy of the final draft with you before distributing
the questionnaire to the NGDF members'
At the completion of my study, I would be happy to shary any of my data with you, and
you have fuIl liherty to publish any portion of my thesis in the NGDF newsletter if you
wish.
Thank you for considering this request. Please feel free to contact me with any questions'
you can also contact my ihesis advisor if you wish. Her name is Dawn Ludwig, Ph'D',
pA-C and her telephone number is (6lZ) jgo-r331. Her e-mail is ludwig@augsburg-edu'
Sincerely,
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JanuarY 8, 2003
Jennifer Gustafson
1020 Feltl Coutt
Apt 106
Minnetonka, MN
5 5343
Dear Jennifer,
It is indeed my pleas*re to inform you that yo* have permission 
to contact
the active mem.bers of the National Graves' Disease 
For-rndation for your research'
I have enjoyed working with you, and rook forward to seeing 
the resuhs of
your work.
SincerelY,
LD
NancY H. Pattersoq Pm
Executive Director
Natioual Gtanes' Dis€ase Fouudation
I
FoBorlgfgrBnevard.NorthCardina.zttlltUsA.(s}E)gTl-5251
\tlebeite: www.ngdf,o[g' +mail: ngd@citcomnet
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Institutional Research Board
Augsburg College
Box 107
May 13, 2003
To: Jennifer Gustafson
From: Norma C. Noonan, Chair ,.rL'+-'7*.{-
I am pleased to inform you that the IRB has approved your application for
the project: Quaffty of Life in Patients with Graves' Disease
as submitted
--x 
_ 
as revised with the additional form(s)/changes
- 
with the following conditions:
your IRB approval number which should be noted in yor.r written project and in any
major documents alluding to the research project is as follows:
2003-30-2
I wish you success with your project. If you have any quo$tions, you may contact me:
6 12-330- 1 198 or nopnan@aggsburg.ed, u.
c. Dr. Dawn Ludwig
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Quality of Life in Individuals with Graves' Disease
Consent Form
you are invited to be in a research study of people with Graves' disease. You were selected as a
possible participant because you are an active member of the National Graves' Disease
houndation. If you are under the age of 18, please discard this survey. I ask that you read this
form before completing the survey.
This study is being conducted by Jennifer Gustafson as part of my master's thesis in I'hysician
Assistant Studies at Augsburg College in Minneapolis, Minnesota'
Background Info rmation :
The p-urpose of this study is to identiff any ef[ects, either positive or negative, that Griles'
disease may have on an individual's quality of life"
Risks and Benelits of Being in the Study:
While completing this ru**y, you may encounter emotionally-sensitive questions. If these
questions blco*J too emotionatty distressing to you, please feel free to call your local health care
provider, or the National Graves'-Disease Foundation at l-828-877-5251- If you should decide to
lontact your heatth cafe provider, all expenses are your responsibihty'
There are no direct benef,rts to you for participating in this study, but there are indirect lbenefits.
By participating in this study, you will-be helping to increase awareness'of GraYes' disrmse and
the many ways it ** affect your life. You will be indirectly benefiting yourself, health care
providers, *d other people with Graves' disease by adding to the general knowledge regarding
this disease.
Confidentiality:
The researcher will not retain any of the names or addresses of those receiving the surv()y. ln
addition, you are asked not to write your name or address on your questionnaire or return
envelope. e tnirO party, who has signed a letter of confidentiality, will be opening all rtrturned
questionnaires and'de#oying the post-marked envelopes and any return addresses and/rlr names
on the envelopes or questionnaires. Therefore, the researcher will have no way of identi,ffing the
respondents. 
'The qulstionnaires will be destroyed after the data has been entered into a statistical
analysis program. This raw data will be destroyed by May, 2004.
Yoluntary Nature of the StudY:
your deoision whether or not to participate will not affect your current or future relationrt with the
National Graves' Disease Foundation or Augsburg College. If you decide to participate, you are
free to skip any question or withdraw at any time without affecting your relationship wiflh the
Foundation or Augsburg College-
Contacts and Questions:
The researcher conducting this study is Jennifer Gustafson. tf you have questions either before or
after completingthe ru**y, you may contact me by phone at (612) 330-1399- You may also
contact my advlsor, Dawrludwig, Ph.D., PA-C at (612) 330-1331, or by e-mail at
ludwig@augsburg.edu.
You may keep this form for your records-
Statement of Consent:
In a written survey of this type, your consent to participate is implied when you complete and
return the survey. DO I$Oi write your name or address on the survey or return envelope.
Researcher: Jennifer Gustafson
IRB Approval # 2003-30-2
flIq.*rs Cofieseundeil Librarv
Minneapolis, MN SS4S4
-.1
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May 8, 2003
To Whom It MaY Concern:
I will be opening any and all guestionnairys rcturnd tI 
-Ey fiancde, Jyrnifer Gustafson 
as part of
t r" tnoi* i*:"Jt *ohu"a "Quality of Life in Graves' Disease-" I uuderstand this is a
confidential questionnaire and I will the,refore remove and destroy any names and/or addresses
that have been inadvertently included with the questionnaires, as well as desnroy the envelope in
which they Game so as to remove auy geographic identifiers. I also pledge not to disolose any of
the respondents' identising information to anyone
1*
(e52) 988-9344
